Today: 7 February 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares slide 2.2% as bank sell-off deepens ahead of Australia CPI test

Westpac shares fell 2.2% to A$38.19 on Tuesday, with about 4 million shares traded, as investors braced for an inflation report due Wednesday. The decline tracked losses across major Australian banks and followed a 0.5% drop in the S&P/ASX 200. Money markets priced a 33% chance of a February rate hike after recent inflation data. Westpac’s first-quarter results are set for February 13.
6 January 2026
·····
IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s loan slump deepens: Q3 update shows advances down 13% and CASA sliding

IndusInd Bank’s net advances fell 13% year-on-year to 3.18 trillion rupees as of December 31, marking a fourth straight quarterly decline. Deposits dropped 3.8% from a year earlier but rose 1.1% from September; the CASA ratio slipped to 30.3%. The bank’s loan contraction contrasts with double-digit growth at larger rivals. IndusInd is recovering from a $230 million derivatives misaccounting scandal.
6 January 2026
NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

NAB slides nearly 3% as rate-hike chatter hits bank stocks ahead of Australia inflation print

National Australia Bank shares fell 3.0% to A$41.28 on Tuesday, underperforming the market as traders braced for Wednesday’s CPI data. Australia’s benchmark index slipped 0.92%, with financials among the main drags. Investors recalibrated for the risk of the Reserve Bank of Australia keeping rates higher for longer. NAB’s next trading update is set for February 18.
6 January 2026
··
Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie shares buck weak ASX as investors eye Qube deadline and May results

Macquarie Group shares rose 1.68% to A$206.76 Tuesday, outperforming the S&P/ASX 200, which fell 0.52%. The stock touched a high of A$207.08 as investors watched for updates on its Qube bid, with the exclusivity deadline set for February 1. No new company filings were posted in the past two days. Macquarie last reported a 3% rise in first-half net profit to A$1.66 billion in November.
6 January 2026
···
BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel stock jumps 21% on A$30 takeover bid — the next catalyst investors are watching

BlueScope Steel shares jumped 20.6% to A$29.48 after SGH and Steel Dynamics made a non-binding A$30-per-share takeover offer. The proposal, received Dec. 12, is subject to due diligence, exclusivity, and other conditions. BlueScope’s board is reviewing the bid against its own valuation. The company previously rejected lower offers, citing execution risks.
6 January 2026
···
DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield stock jumps 18% as ASX:DRO taps Louis Gamarra as chief commercial officer

DroneShield shares surged 18.1% to A$3.91 in Sydney on Tuesday, with turnover more than doubling to 32 million shares. The company named Louis Gamarra chief commercial officer to lead global sales. The rally lifted the stock 27% above its Dec. 31 close, even as the broader ASX 200 fell 0.5%. Investors await the next earnings update for signs of sustained demand.
6 January 2026
··
Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech stock hits a fresh 52-week low as biotech lags — JPMorgan update looms

Legend Biotech shares dropped 4.7% to $20.49 Monday, hitting a 52-week low and leaving the stock down 55% from its high. The decline comes ahead of the J.P. Morgan Healthcare Conference, where CEO Ying Huang is set to present Jan. 14. Broader biotech stocks also fell, with key ETFs down about 1%. Investors are watching for updates on CARVYKTI, Legend’s CAR-T therapy for multiple myeloma.
5 January 2026
·
Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina stock slides after early pop as manufacturing data, peer moves hit sentiment

Sanmina shares fell 5.1% to $151.12 Monday after an early rally above $165 faded, underperforming as Wall Street hit record highs. Electronics manufacturing peers Jabil, Flex, and Celestica also dropped, pressured by weak U.S. manufacturing data and Jabil’s acquisition of Hanley Energy. Investors are awaiting Friday’s U.S. jobs report and Sanmina’s upcoming earnings window.
5 January 2026
·
Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

Wall Street’s buyback boom: GM, Southwest and Tapestry headline 2026’s share-repurchase trade

General Motors, Southwest Airlines, and Tapestry posted buyback yields above 10% after repurchasing $8.2 billion, $2.75 billion, and $2.8 billion in stock in 2025, MarketBeat reported Monday. S&P 500 companies bought back a record $1.02 trillion of stock in the 12 months through September, according to S&P Dow Jones Indices. Investors are watching if companies can sustain repurchases without hurting investment.
5 January 2026
···
NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma shares fell about 5% to $33.42 in afternoon trading Monday after two insiders filed Form 144 notices for proposed stock sales tied to RSU vesting. CFO M. Ian Somaiya and CSO Johannes Kastelein flagged plans to sell a combined 11,118 shares. The stock touched an intraday low of $32.68. Biotech stocks broadly lagged the market ahead of Friday’s U.S. jobs report.
5 January 2026
·
1 … 250 251 252 253 254 … 535

Stock Market Today

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Go toTop